Trial Outcomes & Findings for OSA Screen Negative With Spinal Duramorph (NCT NCT03151226)
NCT ID: NCT03151226
Last Updated: 2018-09-07
Results Overview
defined by values obtained utilizing capnography and pulse oximetry
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
3 participants
Primary outcome timeframe
up to 24 hours
Results posted on
2018-09-07
Participant Flow
Participant milestones
| Measure |
Capnography Monitoring
single arm, all subjects receiving duramorph will receive capnography monitoring
Capnography monitoring: capnography and pulse oximetry will be initiated in the recovery room and worn for 12-24 hours post delivery
|
|---|---|
|
Overall Study
STARTED
|
3
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
Capnography Monitoring
single arm, all subjects receiving duramorph will receive capnography monitoring
Capnography monitoring: capnography and pulse oximetry will be initiated in the recovery room and worn for 12-24 hours post delivery
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
|
Overall Study
not wear device correctly
|
1
|
Baseline Characteristics
OSA Screen Negative With Spinal Duramorph
Baseline characteristics by cohort
| Measure |
Capnography Monitoring
n=3 Participants
single arm, all subjects receiving duramorph will receive capnography monitoring
Capnography monitoring: capnography and pulse oximetry will be initiated in the recovery room and worn for 12-24 hours post delivery
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
3 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
3 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 24 hoursPopulation: the 2 subjects who wore device did not wear the device enough to be evaluable data
defined by values obtained utilizing capnography and pulse oximetry
Outcome measures
Outcome data not reported
Adverse Events
Capnography Monitoring
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place